The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nikunj Mange & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 2.0 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The promoter group of Aspira Pathlab & Diagnostics Ltd, led by Nikunj Velji Mange along with five PACs (Deepali, Raj, Jay, Arvind Karsandas, and Shraddha Bhanushali), acquired 22,82,507 equity shares representing 22.18% of the company's share capital through an open offer completed on 08/06/2026. Prior to this acquisition, the group's combined holding was 24,52,111 shares (23.82%), and after the acquisition it has risen to 47,34,618 shares (46.00%). The total equity share capital of the company stands at Rs. 10.29 crore divided into 1,02,93,000 equity shares of Rs. 10 each. This is part of a mandatory open offer triggered under SEBI Takeover Regulations, significantly increasing promoter control in the company.
Promoter group holding has nearly doubled from 23.82% to 46.00%, signaling strong promoter commitment and tighter control over the company. While this is positive for governance stability, the acquirers remain just below the 50% threshold, meaning the company may still be vulnerable to further takeover activity.